Kiyoshi Matsui Selected Research

Antineutrophil Cytoplasmic Antibodies (ANCA)

12/2023	Association between hypogammaglobulinaemia and severe infections during induction therapy in ANCA-associated vasculitis: from J-CANVAS study.
1/2023	Seasonal Influence on Development of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Cohort Study Conducted at Multiple Institutions in Japan (J-CANVAS).
12/2022	Serum B cell activating factor (BAFF) as a biomarker for induction of remission with rituximab in ANCA-associated vasculitis.
1/2022	Hypertrophic pachymeningitis in ANCA-associated vasculitis: a cross-sectional and multi-institutional study in Japan (J-CANVAS).
1/2021	Increased Circulating Cell-Free DNA in Eosinophilic Granulomatosis With Polyangiitis: Implications for Eosinophil Extracellular Traps and Immunothrombosis.
1/2010	Case of refractory otitis media with high-titer positive serum MPO-ANCA value.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kiyoshi Matsui Research Topics

Disease

16	Rheumatoid Arthritis 01/2024 - 12/2003
8	Inflammation (Inflammations) 01/2023 - 06/2006
5	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 12/2023 - 01/2022
5	Vasculitis (Vasculitides) 12/2023 - 01/2010
5	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2022 - 07/2002
4	Necrosis 01/2024 - 03/2010
3	Infections 04/2024 - 06/2006
3	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2021 - 10/2010
3	Fever (Fevers) 09/2019 - 01/2016
3	Dermatomyositis (Dermatopolymyositis) 09/2019 - 07/2003
3	Arthritis (Polyarthritis) 01/2015 - 12/2003
3	Asthma (Bronchial Asthma) 07/2010 - 09/2007
3	Poisoning 07/2008 - 07/2006
2	Pain (Aches) 01/2023 - 02/2018
2	Ankylosing Spondylitis 08/2022 - 01/2015
2	Pneumonia (Pneumonitis) 09/2019 - 07/2003
2	Melanoma (Melanoma, Malignant) 09/2019 - 01/2016
2	Amyopathic dermatomyositis 09/2019 - 01/2016
2	Experimental Arthritis 10/2018 - 12/2003
2	Polymyositis 01/2017 - 01/2016
2	Eosinophilia 01/2017 - 01/2014
2	Bacterial Infections (Bacterial Infection) 01/2011 - 08/2005
2	Fibrosis (Cirrhosis) 10/2010 - 09/2007
2	Respiratory Hypersensitivity 07/2010 - 09/2007
2	Atopic Dermatitis (Atopic Eczema) 06/2006 - 05/2003
2	Osteoarthritis 12/2003 - 03/2002
1	Microscopic Polyangiitis 04/2024
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 04/2024
1	Renal Insufficiency (Renal Failure) 04/2024
1	Discoid Lupus Erythematosus 04/2024
1	Alopecia (Baldness) 04/2024
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2024
1	Spontaneous Remission 01/2024
1	Lung Diseases (Lung Disease) 10/2023
1	Anisakiasis 01/2023
1	Anaphylaxis (Anaphylactic Shock) 01/2023
1	Non-Radiographic Axial Spondyloarthritis 08/2022
1	Autoimmune Diseases (Autoimmune Disease) 07/2022
1	Collagen Diseases (Collagen Disease) 05/2022
1	Meningitis 01/2022
1	Thromboinflammation 01/2021
1	Churg-Strauss Syndrome (Allergic Angiitis) 01/2021

Drug/Important Bio-Agent (IBA)

10	Interleukin-18 (Interleukin 18)IBA 07/2010 - 03/2002
6	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 12/2023 - 01/2010
4	CytokinesIBA 01/2024 - 05/2004
4	C-Reactive ProteinIBA 01/2023 - 01/2015
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2003
4	Anti-Bacterial Agents (Antibiotics)IBA 09/2019 - 01/2010
4	AntibodiesIBA 09/2019 - 07/2010
3	tocilizumab (atlizumab)FDA Link 01/2024 - 01/2017
3	Antirheumatic Agents (DMARD)IBA 01/2024 - 11/2016
3	Abatacept (Orencia)FDA Link 05/2023 - 11/2016
3	Cell-Free Nucleic AcidsIBA 01/2023 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 12/2022 - 05/2008
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2010 - 12/2003
2	InterleukinsIBA 01/2024 - 09/2019
2	Complementary DNA (cDNA)IBA 07/2022 - 11/2003
2	Infliximab (Remicade)FDA Link 01/2020 - 01/2017
2	CollagenIBA 01/2018 - 10/2010
2	AutoantibodiesIBA 01/2018 - 01/2016
2	Colchicine FDA LinkGeneric 01/2017 - 01/2016
2	Adalimumab (Humira)FDA Link 01/2017 - 01/2015
2	Prednisolone (Predate)FDA LinkGeneric 01/2017 - 01/2015
2	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2016 - 01/2016
2	Staphylococcal Protein A (Protein A)IBA 07/2010 - 05/2003
2	Interleukin-13IBA 07/2010 - 09/2007
2	OvalbuminIBA 07/2010 - 09/2007
2	Immunoglobulin E (IgE)IBA 05/2008 - 05/2003
1	Methylprednisolone FDA LinkGeneric 04/2024
1	anifrolumabIBA 04/2024
1	GlucocorticoidsIBA 04/2024
1	belimumabIBA 04/2024
1	Interferon Type IIBA 04/2024
1	Immunosuppressive Agents (Immunosuppressants)IBA 04/2024
1	Janus Kinase InhibitorsIBA 01/2024
1	Immunoglobulin G (IgG)IBA 12/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2023
1	cyclic citrullinated peptideIBA 05/2023
1	Peptides (Polypeptides)IBA 05/2023
1	ametantrone (HAQ)IBA 01/2023
1	tofacitinibIBA 01/2023
1	Tumor Necrosis Factor InhibitorsIBA 01/2023
1	NF-kappa B (NF-kB)IBA 01/2023
1	AllergensIBA 01/2023
1	Toll-Like Receptor 9IBA 01/2023
1	Rituximab (Mabthera)FDA Link 12/2022
1	B-Cell Activating FactorIBA 12/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 08/2022
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 07/2022
1	Denosumab FDA Link 05/2022
1	Gallium-67IBA 09/2021
1	Deoxyribonucleases (DNase)FDA Link 01/2021
1	Warfarin (Coumadin)FDA LinkGeneric 01/2020

Therapy/Procedure

11	Therapeutics 04/2024 - 12/2003
4	Aftercare (After-Treatment) 04/2024 - 07/2022
4	Remission Induction 12/2023 - 09/2019
2	Transplantation 07/2022 - 01/2014
2	Stem Cell Transplantation 11/2004 - 05/2004
1	Hematopoietic Stem Cell Transplantation 07/2022
1	Drug Therapy (Chemotherapy) 01/2021